Endava PLC (DAVA) is not a strong buy at the moment due to weak financial performance, bearish technical indicators, and lack of significant positive catalysts. For a beginner investor with a long-term focus, it is better to hold off on investing in this stock until there are clearer signs of recovery or growth.
The technical indicators suggest a bearish trend. The MACD is below zero and negatively contracting, RSI is neutral at 34.117, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 4.359 and S2 at 4.187.

NULL identified. No recent news or significant trading trends from hedge funds or insiders. Analysts note undemanding valuation and healthy free cash flow, but improvements are expected to take time.
Analysts have lowered price targets recently, and technical indicators are bearish. No recent congress trading data or news to support a positive sentiment.
In Q2 2026, revenue dropped by -5.88% YoY to $184.1M, net income fell by -200.80% YoY to -$6.91M, EPS declined by -218.18% YoY to -$0.13, and gross margin decreased by -11.29% YoY to 20.42%.
Analysts have recently lowered price targets. TD Cowen reduced the target to $6.50 from $8 with a Hold rating, JPMorgan reduced it to $9 from $10 with a Neutral rating, and Guggenheim reduced it to $13 from $15 but maintains a Buy rating due to undemanding valuation and healthy free cash flow.